TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|---|---|---|---|---|---|---|---|---|---|---|
P | %ret | 1 | 1 | 4 | 4 | 2 | 4 | 12 | -15 | -8 | -0 |
P | %wins | 100 | 50 | 75 | 75 | 50 | 50 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/10 17:19 | 3/19/10 | LXRX | Lexicon Pharmaceuticals, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Ulys, LLC | NY | T | P | 108,411 | 1.15 | 1 | 94,270 | 29,783 | I | -34 | 25 | -48 | -28 | -22 | -28 | -18 | -9 | 5 | 10 | 19 | 5 | 10 | 43 | ||
10/15/09 16:01 | 10/14/09 | LXRX | Lexicon Pharmaceuticals, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Ulys, LLC | NY | T | P.m | 23,183 | 1.50 | 0 | 15,455 | 28 | 70,840 | I | -61 | 17 | 50 | 10 | 9 | -29 | -18 | 2 | 3 | 1 | -9 | 34 | 3 | 10 | |
5/2/08 11:49 | 4/30/08 | LXRX | Lexicon Pharmaceuticals, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Ulys, LLC | NY | T | P | 1,338 | 2.00 | 0 | 669 | 1 | 55,385 | I | -58 | -39 | -46 | -11 | -3 | 6 | 1 | 1 | 6 | -3 | 0 | 17 | -36 | -45 | |
8/24/07 15:26 | 8/23/07 | LXRX | Lexicon Pharmaceuticals, Inc./de | DE | Health | Drug | Pharmaceutical Preparations | Ulys, LLC | NY | T | P.e | 205,473 | 4.04 | 0 | 50,825 | 999% | 54,716 | I | -29 | -18 | -25 | -5 | -4 | 2 | 2 | 4 | 1 | -1 | 6 | -9 | -38 | -38 |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |